Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study
Author:
Funder
Novartis Pharmaceuticals Corporation
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck;Ansara;J. Clin. Pharm. Ther.,2016
2. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact
3. Angiotensin–neprilysin inhibition versus enalapril in heart failure;McMurray;N. Engl. J. Med.,2014
4. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure;Packer;Circulation,2015
5. Angioedema induced by cardiovascular drugs: new players join old friends;Bas;Allergy,2015
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus;Journal of Allergy and Clinical Immunology;2024-08
2. Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals;Molecular Pharmaceutics;2024-05-30
3. The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data;International Journal of Cardiology;2024-02
4. Medikamente als Auslöser Bradykinin‐vermittelter Angioödeme – mehr als ACE‐Hemmer;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-11
5. Possible role of LCZ696 in atherosclerosis: new inroads and perspective;Molecular and Cellular Biochemistry;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3